Showcase Your Work
Applications are now open for this year's poster session. This is an exclusive opportunity to share what you are currently working on, allowing you to:
- Demonstrate your thought leadership in this dynamic field
- Gain visibility and exposure in showcasing your innovations
- Engage in meaningful discussions with industry peers to receive direct feedback
- Attract the attention of industry stakeholders and collaborators
How to Submit Your Poster
- You must first register your place to attend the 7th Gene Therapy Analytical Development Summit Europe
- Submit an abstract for review to showcase your poster during the Scientific Poster Session
- You will be notified once your abstract has been accepted along with details of printing and size requirements. We do request an online PDF of the poster 2 weeks prior to the summit
- Scientific Poster Session: 6th May 2026
- Abstract Submission Deadline: 24th April 2026
T&Cs
- Posters should not be used for sales and marketing purposes
- If your company offers pay-for services, you will need to submit your poster request to our partnerships team - sponsor@hansonwade.com
- All abstracts are subject to approval by the conference organisers, who reserve the right to reject submissions
Explore the Agenda
- 16+ expert speakers from the likes of AAVantgarde, UCB, PureSpring Therapeutics, Regeneron, and UniQure
- 3 days of cutting-edge analytical and QC content addressing the toughest challenges in potency assurance, product characterisation, and analytical readiness across gene therapy platforms
- 6 hours of immersive, case-study led sessions tackling both earlier stage analytical development and later stage QC challenges
- Regulatory-led sessions featuring voices from the Medicines and Healthcare products Regulatory Agency (MHRA) with pharmacopeial insights
